P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class
Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. Peptide-based enzyme inhibitors, usually short sequences of three or four residues, are one of the classe...
Gespeichert in:
Veröffentlicht in: | RSC chemical biology 2023-08, Vol.4 (8), p.533-547 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 547 |
---|---|
container_issue | 8 |
container_start_page | 533 |
container_title | RSC chemical biology |
container_volume | 4 |
creator | Stubbing, Louise A Hubert, Jonathan G Bell-Tyrer, Joseph Hermant, Yann O Yang, Sung Hyun McSweeney, Alice M McKenzie-Goldsmith, Geena M Ward, Vernon K Furkert, Daniel P Brimble, Margaret A |
description | Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. Peptide-based enzyme inhibitors, usually short sequences of three or four residues, are one of the classes of compounds currently under development for enhancement of their activity and pharmaceutical properties. This review reports the advances made in the design of inhibitors targeting the family of highly conserved viral proteases 3C/3CL
pro
, which play a key role in viral replication and present minimal homology with mammalian proteases. Particular focus is put on the reported development of P
1
glutamine isosteres to generate potent inhibitors mimicking the natural substrate sequence at the site of recognition.’
Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. |
doi_str_mv | 10.1039/d3cb00075c |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10398354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2847346208</sourcerecordid><originalsourceid>FETCH-LOGICAL-p244t-77a05a4d82919f6efb0811bfc7b6fb34e53d57947367bdd8394a0a221ff39bb33</originalsourceid><addsrcrecordid>eNpVkE1LxDAQhoMguKx78Rfk6KVuvto0J5HiFyy4Bz2XpJ1sI21Tk3TBf29X9-JpmOedeQYGoRtK7ijhatvyxhBCZN5coBUrOM9IIdUV2sT4uXCWU6qUXKG4p_i5n5Me3AjYRR8TBIjYjTh1gFuI7jBibxfQOeOSD_HU8WrLqx2egk-gI5xQNw96xEcX5gi_M6f9_WIc3QJdA2nBTa9jvEaXVvcRNue6Rh9Pj-_VS7Z7e36tHnbZxIRImZSa5Fq0JVNU2QKsISWlxjbSFNZwATlvc6mE5IU0bVtyJTTRjFFruTKG8zW6__NOsxmgbWBMQff1FNygw3fttav_J6Pr6oM_1qcPljwXi-H2bAj-a4aY6sHFBvpej-DnWLNyuS4KRkr-A7nmdPI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2847346208</pqid></control><display><type>article</type><title>P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class</title><source>Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Stubbing, Louise A ; Hubert, Jonathan G ; Bell-Tyrer, Joseph ; Hermant, Yann O ; Yang, Sung Hyun ; McSweeney, Alice M ; McKenzie-Goldsmith, Geena M ; Ward, Vernon K ; Furkert, Daniel P ; Brimble, Margaret A</creator><creatorcontrib>Stubbing, Louise A ; Hubert, Jonathan G ; Bell-Tyrer, Joseph ; Hermant, Yann O ; Yang, Sung Hyun ; McSweeney, Alice M ; McKenzie-Goldsmith, Geena M ; Ward, Vernon K ; Furkert, Daniel P ; Brimble, Margaret A</creatorcontrib><description>Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. Peptide-based enzyme inhibitors, usually short sequences of three or four residues, are one of the classes of compounds currently under development for enhancement of their activity and pharmaceutical properties. This review reports the advances made in the design of inhibitors targeting the family of highly conserved viral proteases 3C/3CL
pro
, which play a key role in viral replication and present minimal homology with mammalian proteases. Particular focus is put on the reported development of P
1
glutamine isosteres to generate potent inhibitors mimicking the natural substrate sequence at the site of recognition.’
Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases.</description><identifier>EISSN: 2633-0679</identifier><identifier>DOI: 10.1039/d3cb00075c</identifier><language>eng</language><publisher>RSC</publisher><subject>Chemistry</subject><ispartof>RSC chemical biology, 2023-08, Vol.4 (8), p.533-547</ispartof><rights>This journal is © The Royal Society of Chemistry 2023 RSC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398354/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398354/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Stubbing, Louise A</creatorcontrib><creatorcontrib>Hubert, Jonathan G</creatorcontrib><creatorcontrib>Bell-Tyrer, Joseph</creatorcontrib><creatorcontrib>Hermant, Yann O</creatorcontrib><creatorcontrib>Yang, Sung Hyun</creatorcontrib><creatorcontrib>McSweeney, Alice M</creatorcontrib><creatorcontrib>McKenzie-Goldsmith, Geena M</creatorcontrib><creatorcontrib>Ward, Vernon K</creatorcontrib><creatorcontrib>Furkert, Daniel P</creatorcontrib><creatorcontrib>Brimble, Margaret A</creatorcontrib><title>P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class</title><title>RSC chemical biology</title><description>Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. Peptide-based enzyme inhibitors, usually short sequences of three or four residues, are one of the classes of compounds currently under development for enhancement of their activity and pharmaceutical properties. This review reports the advances made in the design of inhibitors targeting the family of highly conserved viral proteases 3C/3CL
pro
, which play a key role in viral replication and present minimal homology with mammalian proteases. Particular focus is put on the reported development of P
1
glutamine isosteres to generate potent inhibitors mimicking the natural substrate sequence at the site of recognition.’
Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases.</description><subject>Chemistry</subject><issn>2633-0679</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LxDAQhoMguKx78Rfk6KVuvto0J5HiFyy4Bz2XpJ1sI21Tk3TBf29X9-JpmOedeQYGoRtK7ijhatvyxhBCZN5coBUrOM9IIdUV2sT4uXCWU6qUXKG4p_i5n5Me3AjYRR8TBIjYjTh1gFuI7jBibxfQOeOSD_HU8WrLqx2egk-gI5xQNw96xEcX5gi_M6f9_WIc3QJdA2nBTa9jvEaXVvcRNue6Rh9Pj-_VS7Z7e36tHnbZxIRImZSa5Fq0JVNU2QKsISWlxjbSFNZwATlvc6mE5IU0bVtyJTTRjFFruTKG8zW6__NOsxmgbWBMQff1FNygw3fttav_J6Pr6oM_1qcPljwXi-H2bAj-a4aY6sHFBvpej-DnWLNyuS4KRkr-A7nmdPI</recordid><startdate>20230803</startdate><enddate>20230803</enddate><creator>Stubbing, Louise A</creator><creator>Hubert, Jonathan G</creator><creator>Bell-Tyrer, Joseph</creator><creator>Hermant, Yann O</creator><creator>Yang, Sung Hyun</creator><creator>McSweeney, Alice M</creator><creator>McKenzie-Goldsmith, Geena M</creator><creator>Ward, Vernon K</creator><creator>Furkert, Daniel P</creator><creator>Brimble, Margaret A</creator><general>RSC</general><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230803</creationdate><title>P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class</title><author>Stubbing, Louise A ; Hubert, Jonathan G ; Bell-Tyrer, Joseph ; Hermant, Yann O ; Yang, Sung Hyun ; McSweeney, Alice M ; McKenzie-Goldsmith, Geena M ; Ward, Vernon K ; Furkert, Daniel P ; Brimble, Margaret A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p244t-77a05a4d82919f6efb0811bfc7b6fb34e53d57947367bdd8394a0a221ff39bb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stubbing, Louise A</creatorcontrib><creatorcontrib>Hubert, Jonathan G</creatorcontrib><creatorcontrib>Bell-Tyrer, Joseph</creatorcontrib><creatorcontrib>Hermant, Yann O</creatorcontrib><creatorcontrib>Yang, Sung Hyun</creatorcontrib><creatorcontrib>McSweeney, Alice M</creatorcontrib><creatorcontrib>McKenzie-Goldsmith, Geena M</creatorcontrib><creatorcontrib>Ward, Vernon K</creatorcontrib><creatorcontrib>Furkert, Daniel P</creatorcontrib><creatorcontrib>Brimble, Margaret A</creatorcontrib><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>RSC chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stubbing, Louise A</au><au>Hubert, Jonathan G</au><au>Bell-Tyrer, Joseph</au><au>Hermant, Yann O</au><au>Yang, Sung Hyun</au><au>McSweeney, Alice M</au><au>McKenzie-Goldsmith, Geena M</au><au>Ward, Vernon K</au><au>Furkert, Daniel P</au><au>Brimble, Margaret A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class</atitle><jtitle>RSC chemical biology</jtitle><date>2023-08-03</date><risdate>2023</risdate><volume>4</volume><issue>8</issue><spage>533</spage><epage>547</epage><pages>533-547</pages><eissn>2633-0679</eissn><abstract>Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases. Peptide-based enzyme inhibitors, usually short sequences of three or four residues, are one of the classes of compounds currently under development for enhancement of their activity and pharmaceutical properties. This review reports the advances made in the design of inhibitors targeting the family of highly conserved viral proteases 3C/3CL
pro
, which play a key role in viral replication and present minimal homology with mammalian proteases. Particular focus is put on the reported development of P
1
glutamine isosteres to generate potent inhibitors mimicking the natural substrate sequence at the site of recognition.’
Viral infections are one of the leading causes of acute morbidity in humans and much endeavour has been made by the synthetic community for the development of drugs to treat associated diseases.</abstract><pub>RSC</pub><doi>10.1039/d3cb00075c</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2633-0679 |
ispartof | RSC chemical biology, 2023-08, Vol.4 (8), p.533-547 |
issn | 2633-0679 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10398354 |
source | Directory of Open Access Journals; PubMed Central Open Access; PubMed Central; EZB Electronic Journals Library |
subjects | Chemistry |
title | P1 Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the Pisoniviricetes class |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A51%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P1%20Glutamine%20isosteres%20in%20the%20design%20of%20inhibitors%20of%203C/3CL%20protease%20of%20human%20viruses%20of%20the%20Pisoniviricetes%20class&rft.jtitle=RSC%20chemical%20biology&rft.au=Stubbing,%20Louise%20A&rft.date=2023-08-03&rft.volume=4&rft.issue=8&rft.spage=533&rft.epage=547&rft.pages=533-547&rft.eissn=2633-0679&rft_id=info:doi/10.1039/d3cb00075c&rft_dat=%3Cproquest_pubme%3E2847346208%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2847346208&rft_id=info:pmid/&rfr_iscdi=true |